1-4 of 4
HANS MEIER
Close
Sort by
Journal Articles

High-dose melphalan and stem cell transplantation for patients with AL amyloidosis: trends in treatment-related mortality over the past 17 years at a single referral center

Stephanie B. Tsai, David C. Seldin, Karen Quillen, John L. Berk, Frederick L. Ruberg, Hans Meier-Ewert, J. Mark Sloan, Gheorghe Doros, Kathleen T. Finn, Martha Skinner, Vaishali Sanchorawala
Journal: Blood
Blood (2012) 120 (22): 4445–4446.
https://doi.org/10.1182/blood-2012-09-457341
Published: 2012
Journal Articles

High-Dose Melphalan and Stem Cell Transplantation for Patients with AL Amyloidosis and Cardiac Involvement

Saulius Girnius, M.D., David C Seldin, MD, PhD, Karen Quillen, MD, MPH, Nancy T Andrea, MD, John Mark Sloan, MD, John L Berk, MD, Frederick L Ruberg, MD, Hans Meier-Ewert, MD, Vaishali Sanchorawala, MD
Journal: Blood
Blood (2011) 118 (21): 2043.
https://doi.org/10.1182/blood.V118.21.2043.2043
Published: 2011
Journal Articles

Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation: long-term results in a series of 421 patients

Clinical Trials & Observations
Maria Teresa Cibeira, Vaishali Sanchorawala, David C. Seldin, Karen Quillen, John L. Berk, Laura M. Dember, Adam Segal, Frederick Ruberg, Hans Meier-Ewert, Nancy T. Andrea, J. Mark Sloan, Kathleen T. Finn, Gheorghe Doros, Joan Blade, Martha Skinner
Journal: Blood
Blood (2011) 118 (16): 4346–4352.
https://doi.org/10.1182/blood-2011-01-330738
Published: 2011
Journal Articles

Spontaneous Hemorrhagic Diathesis in Inbred Mice Due to Single or Multiple "Prothrombin-Complex" Deficiencies

HANS MEIER, D.V.M., Ph.D., ROBERT C. ALLEN, Ph.D., WARREN G. HOAG, D.V.M., M.P.H.
Journal: Blood
Blood (1962) 19 (4): 501–514.
https://doi.org/10.1182/blood.V19.4.501.501
Published: 1962